The dual mTOR kinase inhibitor, AZD8055, synergises with ibrutinib to induce CLL apoptosis, and overcomes BCR- and stromal-mediated survival advantages conferred in the microenvironment
BRITISH JOURNAL OF HAEMATOLOGY（2018）
Key words
AZD8055,CLL,ibrutinib,microenvironment,mTOR
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined